Biotech stocks have climbed steadily higher over the past few weeks. Still, the iShares Nasdaq Biotechnology ETF (IBB) has remained range bound between $240 and $290 for much of 2016.
So with major stock indices hitting new record highs, can biotech stocks break free? Perhaps, says Michael Yee, the industry analyst for RBC Capital Markets. But first, the market wants the political rhetoric surrounding drug prices to calm down, new positive clinical data and, finally, M&A activity.
Weve said a HC rotation from well owned and big outperforming defensive lower risk yield stocks like med tech should eventually shift a bit into underperforming biotech but generalists feel no rush to do that and think we need visibility on an election and whether the political rhetoric on drug pricing will calm down after the general election is won. As PMs position for 2017, defensive outperformers in 2016 may not be the big winners from a risk/reward standpoint vs underperformers like biotech as we enter and think about 2017 so a rotation is possible.
Top 5 Tech Companies To Buy Right Now: Finisar Corporation(FNSR)
Finisar Corporation provides optical subsystems and components for data communication and telecommunication applications in the United States, Malaysia, China, and internationally. Its optical subsystems primarily consist of transmitters, receivers, transceivers, transponders, and active optical cables that provide the fundamental optical-electrical or optoelectronic interface for interconnecting the electronic equipment used in communication networks, including the switches, routers, and servers used in wireline networks, as well as the antennas and base stations used in wireless networks. The company also offers wavelength selective switches, which are used to switch network traffic from one optical fiber to multiple other fibers without converting to an electronic signal. In addition, it provides optical components comprising packaged lasers, receivers, and photodetectors for data communication and telecommunication applica tions; and passive optical components for telecommunication applications. Finisar Corporation markets its products through its direct sales force, as well as through a network of distributors and manufacturers representatives to the original equipment manufacturers of storage systems, networking equipment, and telecommunication equipment, as well as to their contract manufacturers. Finisar Corporation was founded in 1987 and is headquartered in Sunnyvale, California.
- [By Renu Singh]
Finisar’s (FNSR) datacom segment generated $184.4 million in revenue in the last reported quarter. This was a sequential growth of 9.3%. The Ten Gigabit Ethernet or 10GbE modules contributed about 40% to the datacom segment’s revenue. As organizations go digital, there are an increasing number of applications that require considerable bandwidth to support the transfer of large data, video, and audio files across networks. Using 10GbE optical links provides sufficient bandwidth to support these bandwidth-intensive applications at a lower cost.
- [By Lisa Levin]
Finisar Corporation (NASDAQ: FNSR) shares were also up, gaining 18 percent to $16.70 after the company reported upbeat Q3 earnings.
Equities Trading DOWN
Top 5 Tech Companies To Buy Right Now: Alnylam Pharmaceuticals Inc.(ALNY)
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). Its core product programs under clinical or pre-clinical development include ALN-TTR, a Phase I clinical trial program for the treatment of transthyretin-mediated amyloidosis; ALN-APC, a Phase I clinical trial program for the treatment of hemophilia; ALN-PCS for the treatment of severe hypercholesterolemia; ALN-HPN, a pre-clinical development for the treatment of refractory anemia; and ALN-TMP, a pre-clinical development for the treatment of hemoglobinopathies, including beta-thalassemia and sickle cell anemia. The company?s partner-based programs comprise ALN-RSV01, a Phase II clinical trial program for the treatment of respiratory syncytial virus infection; ALN-VSP, a Phase I clinical trial completed program for the treatment of liver cancers; and ALN-HTT, a pre-clinical development for the treatment of H untington?s disease. It has strategic alliances with Novartis Pharma AG; F. Hoffmann-La Roche Ltd; Takeda Pharmaceutical Company Limited; Isis Pharmaceuticals, Inc.; Medtronic Inc.; Kyowa Hakko Kirin Co., Ltd.; and Cubist Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
- [By Monica Gerson]
Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Friday's regular session.
Caterpillar Inc. (NYSE: CAT) Jan17 77.5 Calls Sweep: 1022 @ ASK $4.45: 1066 traded vs 2466 OI: Earnings 7/28 $75.88 Ref Anacor Pharmaceuticals Inc (NASDAQ: ANAC) Jan17 110 Calls: 500 @ Above Ask! $0.40: 509 traded vs 1860 OI: $99.22 Ref Ctrip.com International, Ltd. (ADR) (NASDAQ: CTRP) Jun16 41.25 Calls Sweep: 577 @ ASK $1.75: 649 traded vs 1927 OI: Earnings 6/15 After Close $40.54 Ref Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Jun16 65.0 Calls Sweep: 749 @ ASK $1.85: 813 traded vs 370 OI: $63.08 Ref WhiteWave Foods Co (NYSE: WWAV) Oct16 50.0 Calls: 600 @ ASK $1.60: 601 traded vs 430 OI: $45.16 Ref
Posted-In: Unusual Put OptionsNews Options Markets
Top Safest Stocks To Invest In Right Now: Cellcom Israel Ltd.(CEL)
Cellcom Israel Ltd. provides cellular communications services in Israel. It offers basic and advanced cellular telephone services, text and multimedia messaging services, and advanced cellular content and data services. The company?s basic cellular telephony services include voice mail, cellular fax, call waiting, call forwarding, caller identification, collect call, conference calling, ?Talk 2?, additional number services, and collect call services; and outbound and inbound roaming services. It also provides value-added services comprising Cellcom volume that includes downloadable content, such as music, games, on-net-reality programs, drama series, and video games; SMS and MMS services to send and receive text, photos, multimedia, and animation messages; access to third party application providers for notification of roadway speed detectors, mange vehicle fleets, and enable subscribers to manage and operate time clocks and various controllers for industrial, agricultural , and commercial purposes; video calls to communicate with each other through video applications; zone services for calls initiated from a specific location; location-based services; voice-based information services; text-based information services and interactive information services, including news headlines, sports results, and traffic and weather reports; and data services to access handsets, cellular modems, laptops, tablets, and cellular routers, as well as Internet based payment services. In addition, the company sells handsets, modems, routers, tablets, and laptops, as well as provides repair and replacement services; and offers landline telephony, transmission, and data services through its approximately 1,500 kilometers of inland fiber-optic infrastructure and complementary microwave links to selected business customers. As of March 31, 2011, it provided its services to approximately 3.395 million subscribers. The company was founded in 1994 and is headquartered i n Netanya, Israel.
- [By Monica Gerson]
Cellcom Israel Ltd. (NYSE: CEL) is estimated to post its earnings for the latest quarter.
Quotient Ltd (NASDAQ: QTNT) is projected to post a quarterly loss at $0.59 per share on revenue of $4.75 million.
Top 5 Tech Companies To Buy Right Now: Illinois Tool Works Inc.(ITW)
Illinois Tool Works Inc. manufactures and sells industrial products and equipment worldwide. It operates through seven segments: Automotive OEM; Test & Measurement and Electronics; Food Equipment; Polymers & Fluids; Welding; Construction Products; and Specialty Products. The Automotive OEM segment produces components and fasteners for automotive-related applications. The Test & Measurement and Electronics segment provides equipment, consumables, and related software for testing and measuring of materials and structures, as well as equipment and consumables used in the production of electronic subassemblies and microelectronics. The Food Equipment segment offers commercial food equipment and related services. The Polymers & Fluids segment produces adhesives, sealants, lubrication and cutting fluids, and fluids and polymers for auto aftermarket maintenance and appearance. The Welding segment produces arc welding equipment, consu mables, and accessories for various industrial and commercial applications. The Construction Products segment produces engineered fastening systems and solutions. The Specialty Products segment provides beverage packaging equipment and consumables, product coding and marking equipment and consumables, and appliance components and fasteners. The company distributes its products directly to industrial manufacturers, as well as through independent distributors. Illinois Tool Works Inc. was founded in 1912 and is headquartered in Glenview, Illinois.
- [By Ben Levisohn]
Technology and Industrials are our favorite ways to buy cyclical MO. Specifically, we see the Technology Select Sector SPDR ETF (XLK) as an attractive pre-breakout idea and a likely candidate to lead the S&Ps secular advance over the coming years. Buy ideas at the stock level include: Accenture (ACN), Broadcom (AVGO), Microsoft , Texas Instruments (TXN),Visa (V),Yahoo! (YHOO). We also recommend buying the Industrial Select Sector SPDR ETF (XLI) which is reversing its year-long downtrend and in position for new highs over the coming months, in our view. Buy ideas at the stock level include: Honeywell International, Ingersoll-Rand (IR), Illinois Tool Works (ITW), 3M, Southwest Airlines (LUV), Xylem (XYL). Underlined stocks are fundamentally-rated Outperform at Oppenheimer.
Top 5 Tech Companies To Buy Right Now: Veeva Systems Inc.(VEEV)
Veeva Systems Inc. (Veeva), incorporated on January 12, 2007, is a provider of cloud-based software solutions for the global life sciences industry. The Company offers solutions for a range of requirements within life sciences companies, including multichannel customer relationship management, regulated content and information management, master data management and customer data. The Company offers solutions to areas, including the Veeva CRM family of applications for multichannel customer relationship management to enable coordinated and personalized customer engagement through multiple touch points; Veeva Vault for regulated content management and information management solutions to enable the management of content-centric processes; the Veeva Network master data management solutions for the management of customer master and product master data, and Veeva’s data and data services offerings, including Veeva OpenData for customer reference data and Veeva KOL Data for data.
The Company’s professional services include implementation and deployment planning and project management; requirements analysis, solution design and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on solutions, and ongoing managed services, such as outsourced systems administration. The Company offers Veeva Commercial Cloud for the commercial function of life sciences companies.
Multichannel Customer Relationship Management
Veeva CRM, the Company’s multichannel customer relationship management solutions, allow pharmaceutical and biotechnology companies to market and sell to physicians, other healthcare professionals and healthcare organizations across multiple touch points, including in-person, e-mail and online. Veev a CRM provides specialized functionality, such as prescripti! on drug sample management with electronic signature capture, the management of complex affiliations between physicians and the organizations where they work, and the capture of medical inquiries from physicians. The Company has designed and built a specific application for each mobile device platform it support, including Apple iPads, Windows 8 and 10 mobile devices, Windows-based laptops and tablet personal computers (PC).
The Company’s Veeva CRM and Veeva Medical CRM enables physician-facing employees, such as pharmaceutical sales representatives, key account managers and scientific liaisons to manage, track and optimize interactions with healthcare professionals utilizing a single, integrated solution. Its Veeva CLM provides closed-loop marketing capabilities for use in in-person interactions with physicians. Veeva CLM allows customers to replace paper-based materials with interactive electronic marketing presentations while controlling the storage, distribut ion, presentation and tracking of promotional materials. Its Veeva CRM Mobile is a mobile application that runs on the Apple iPad and the Windows 8 and 10 platforms, combines the key functionality of Veeva CRM and Veeva CLM to provide users with functionality that helps maximize productivity in the field. Veeva CRM Mobile was designed to provide the functionality needed for pharmaceutical field sales representatives and other users to finish tasks in locations, such as hospitals and physicians’ offices, whether or not an Internet connection is available. Its Veeva CRM Approved Email provides for the management, delivery and tracking of regulatory compliant e-mail communication between sales representatives and physicians.
The Company’s Veeva CRM Engage provides closed-loop marketing capabilities for self-directed physician interactions via the Web. The Company’s Veeva CRM CoBrowse provides closed-loop marketing capabilities for Web-based presentations to physici ans led by the sales and marketing staff of life sciences co! mpanies. ! Its Veeva CRM Events Management enables the planning, management and execution of group meetings with healthcare professionals, and helps life sciences companies track and manage spending in order to meet transparency reporting requirements. Its Veeva Align enables life sciences companies to manage the allocation and alignment of sales and marketing resources to customers across various communication channels and define multichannel plans of action.
Regulated Content Management and Collaboration
Veeva Vault, its cloud-based content and information management solution, is used by its customers across commercial functions, including medical, sales and marketing, and research and development (R&D) functions, including clinical, regulatory and quality. Veeva Vault consists of over nine business applications and its Veeva Vault Platform. Veeva Vault applications each include a data model, deep functionality, and pre-defined workflows required to support specific industry processes. Veeva Vault can be deployed as an integrated solution across multiple applications, enabling its customers to manage various important documents and related data in a single, global system. The Veeva Vault Platform was built with the content and information management requirements of the life sciences industry in mind, including audit trail capabilities that record actions and updates enabling customers to manage their regulated content and data in a compliant manner. In addition, the Veeva Vault Platform offers functionality across various the Veeva Vault applications, such as searching, content viewing and annotation, workflow and approvals, electronic signatures, reporting and open application programming interfaces to allow for integration with other systems. The Veeva Vault Platform also includes a configuration toolset that allows customers to create their own Veeva Vault applications.
Veeva Vault applications primarily for use by research and development departments of life sciences co! mpanies i! nclude Veeva Vault eTMF, which is an electronic trial master file application that manages the repository of important documents for active and archived clinical trials and also enables collaboration between the life sciences company sponsoring the trial and its outsourced partners; Veeva Vault Study Startup enables life sciences companies to manage the process of activating investigator sites for clinical trials, accelerating time to first patient enrollment and automating complicated processes while helping to maintain compliance with regulatory requirements and connectivity with Vault eTMF; Veeva Vault Investigator Portal, which manages the collection of documentation and collaboration among trial sponsors, trial sites and the researchers conducting the trials, known as investigators; Veeva Vault QualityDocs enables the creation, review, approval, distribution and management of controlled documents, such as standard operating procedures (SOPs), manufacturing recipes and s pecifications, and Veeva Vault Submissions, which helps life sciences companies to gather and organize all the documents and other content that will be included in a regulatory submission to a healthcare authority, such as the Food and Drug Administration (FDA).
The Company’s Veeva Vault Registrations enables life sciences companies to manage, track and report product and registration information around the world, including registration status, variations, health authority questions and commitments and certification requests. Its Veeva Vault SubmissionsArchive is an authoritative source for submissions and correspondence that stores published submissions in a secure, globally accessible repository. Its Veeva Vault PromoMats enables life sciences companies to manage the end-to-end process for creation, approval, distribution, expiration and withdrawal of commercial content across the digital supply chain. Its Veeva Vault MedComms provides life sciences companies with a single, validated source of medical content across mu! ltiple ch! annels and geographies.
Master Data Management
Veeva Network Customer Master, the Company’s cloud-based customer master and data management solution, is designed to help life sciences companies create and maintain a single, complete and accurate record of the healthcare professionals and healthcare organizations. Veeva Network Customer Master is an industry-specific, cloud-based customer master software solution that de-duplicates, standardizes and cleanses healthcare professional and organization data from multiple systems and data sources to arrive at a single, consolidated customer master record. Veeva Network Customer Master comes pre-configured with a data model that is specific to life sciences and supports global harmonization, as well as country, market and regional data specifications within a single system. Veeva Network Customer Master also includes an intuitive user interface, free text search and filtering capabilities, and the ability to track and measure data quality and operating efficiency through key performance indicators.
Veeva Network Customer Master can be used with Veeva OpenData to simplify the process of data delivery to customers and provide bi-directional integration of requests for data enrichment. Additionally, eeva Network Customer Master can be operated in what it refers to as private mode when data from third-party data providers is uploaded to the Veeva Network solution. In private mode, the bi-directional integration between Veeva Network Customer Master and Veeva OpenData is disabled. Veeva Network Customer Master is also fully integrated with Veeva CRM in order to make the healthcare professional and healthcare organization data available to sales and marketing users. The Company’s Veeva Network Product Master is a cloud-based product master data management offering to help life sciences companies create complete and accurate product master records.
Data and Data Services
Veeva OpenData Customer Data pro! vides hea! lthcare professional and healthcare organization data that includes demographic and license information, affiliations, and other key data, such as digital profiles crucial to customer engagement and compliance. Its Veeva OpenData Compliance Data identifies and assigns healthcare professional specialty information and license status, including expiration dates, which are required to the compliance processes with respect to certain life sciences activities, such as confirming drug sample eligibility and assigning sales territories. Its Veeva OpenData Data Services manage healthcare professional and healthcare organization data. Its Veeva OpenData Email Services provides e-mail data and e-mail rental services to help improve outreach to healthcare professionals through digital channels. Its Veeva KOL Data and Services provide profile information for important healthcare professionals and other stakeholders, gathered from their conference presentations, published research, clini cal trials, grants, articles and social activity.
The Company competes with Oracle Corporation, IMS Health Holding, Inc., EMC Corporation, Microsoft Corporation, OpenText Corporation and Informatica Corporation.
- [By Lisa Levin]
Veeva Systems Inc (NYSE: VEEV) shares shot up 9 percent to $32.30 after the company reported better-than-expected results for the first quarter and issued a strong revenue forecast for the year.